NCT07599904 REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)
| NCT ID | NCT07599904 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medtronic Neurovascular Clinical Affairs |
| Condition | Acute Ischemic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2026-07-13 |
| Primary Completion | 2031-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2026-07-13 with a primary completion date of 2031-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Post-Market Registry
Eligibility Criteria
Inclusion Criteria: 1. Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements. 2. Participant is treated or intended to be treated with a commercially available Medtronic Neurovascular device\* during treatment for acute ischemic stroke. 3. Participant is 18 years of age or older. Exclusion Criteria: 1. Participant who may be unable to complete follow-up within the registry. 2. Participant of child-bearing potential who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study. 3. Participant is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the study results based on Principal Investigator's discretion.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07599904 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07599904 currently recruiting?
Yes, NCT07599904 is actively recruiting participants. Contact the research team at rs.recanovaregistry@medtronic.com for enrollment information.
Where is the NCT07599904 trial being conducted?
This trial is being conducted at Flint, United States, Buffalo, United States, Houston, United States.
Who is sponsoring the NCT07599904 clinical trial?
NCT07599904 is sponsored by Medtronic Neurovascular Clinical Affairs. The trial plans to enroll 1,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.